News Archive

MarsyasI - clinical phase 1 study completed (31 Mar. 2016)

Marsyas I: A Prospective Randomized Double-Blinded Placebo controlled, explorative Phase I trial to investigate the Safety and Tolerability of two different doses of Topically Administered APOSECTM in Healthy male subjects with Artificial Dermal Wounds, (ClinicalTrials.gov Identifier: NCT02284360) initiated on 23 October 2014 was completed on 5 February 2016: Study Report - Synopsis
PDF Download

 

go back to news archive

Latest News
Aug
31

Approval of DSMB for Lead In-Phase and Go-Ahead for MARSYAS II Main Study

[more]

May
27

Approval for clinical phase II study in DFU by German health agency PEI

[more]